Roles of Protein Disulfide Isomerase in Breast Cancer.
Suhui YangChanel JacksonEduard KarapetyanPranabananda DuttaDulcie KermahYong WuYanyuan WuJohn SchlossJaydutt V VadgamaPublished in: Cancers (2022)
Protein disulfide isomerase (PDI) is the endoplasmic reticulum (ER)'s most abundant and essential enzyme and serves as the primary catalyst for protein folding. Due to its apparent role in supporting the rapid proliferation of cancer cells, the selective blockade of PDI results in apoptosis through sustained activation of UPR pathways. The functions of PDI, especially in cancers, have been extensively studied over a decade, and recent research has explored the use of PDI inhibitors in the treatment of cancers but with focus areas of other cancers, such as brain or ovarian cancer. In this review, we discuss the roles of PDI members in breast cancer and PDI inhibitors used in breast cancer research. Additionally, a few PDI members may be suggested as potential molecular targets for highly metastatic breast cancers, such as TNBC, that require more attention in future research.
Keyphrases
- endoplasmic reticulum
- small cell lung cancer
- protein protein
- amino acid
- squamous cell carcinoma
- binding protein
- signaling pathway
- oxidative stress
- single molecule
- childhood cancer
- cell death
- multidrug resistant
- endoplasmic reticulum stress
- white matter
- magnetic resonance imaging
- risk assessment
- multiple sclerosis
- room temperature
- molecular dynamics simulations
- small molecule
- cell cycle arrest
- quantum dots
- cerebral ischemia
- highly efficient
- smoking cessation
- breast cancer risk
- combination therapy
- blood brain barrier